A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT00047645 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Interferon-gamma 1b

Sponsor

InterMune